SCHEMBL4892687

SCHEMBL4892687

C=CC[SiH2]Nc1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.38
TGM2 P21980 1/20 0.36
ALDH1A1 P00352 5/20 0.35
TDP1 Q9NUW8 3/20 0.35
HSD17B10 Q99714 2/20 0.35
CTSD P07339 1/20 0.35
TSHR P16473 3/20 0.33
PTGS2 P35354 2/20 0.33
MAPT P10636 1/20 0.33
ALOX15 P16050 1/20 0.33
ALOX12 P18054 1/20 0.33
PTGS1 P23219 1/20 0.33
SLC6A2 P23975 1/20 0.33
MAPK1 P28482 1/20 0.33
HTR2B P41595 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
IDO1 P14902 2/20 0.32
CYP2C9 P11712 2/20 0.32
LMNA P02545 2/20 0.32
CYP3A4 P08684 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8080437 0.70 ALDH1A1 (0.42) CYP1A2TGM2ALDH1A1TDP1HSD17B10
SCHEMBL10709581 0.70 TSHR (0.42) CYP1A2ALDH1A1TDP1HSD17B10CTSD
SCHEMBL18991482 0.67 TSHR (0.39) ALDH1A1TDP1HSD17B10CTSDTSHR
SCHEMBL16371883 0.65 CA12 (0.53) CYP1A2TGM2ALDH1A1MAPTL3MBTL1
Biphenyl SCHEMBL28773768 0.65 ALDH1A1 (0.45) CYP1A2ALDH1A1TDP1HSD17B10TSHR
SCHEMBL11051 0.65 CA12 (0.53) CYP1A2TGM2ALDH1A1MAPTL3MBTL1
SCHEMBL463323 0.65 ALDH1A1 (0.36) ALDH1A1TSHRCYP2C19
SCHEMBL17409617 0.65 ALDH1A1 (0.50) CYP1A2ALDH1A1TDP1HSD17B10CTSD
SCHEMBL30814267 0.65 ALDH1A1 (0.50) CYP1A2ALDH1A1TDP1HSD17B10CTSD
SCHEMBL253353 0.64 CA12 (0.52) CYP1A2TGM2ALDH1A1MAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9005719-B2 Organoaminosilane precursors and methods for making and using same AIR PRODUCTS AND CHEMICALS, INC. (US) 2015-04-14 US claimed
US-20140272194-A1 ORGANOAMINOSILANE PRECURSORS AND METHODS FOR MAKING AND USING SAME AIR PRODUCTS AND CHEMICALS, INC. (US) 2014-09-18 US claimed
US-8771807-B2 Organoaminosilane precursors and methods for making and using same AIR PRODUCTS AND CHEMICALS, INC. (US) 2014-07-08 US claimed
US-20130129940-A1 ORGANOAMINOSILANE PRECURSORS AND METHODS FOR MAKING AND USING SAME AIR PRODUCTS AND CHEMICALS, INC. (US) 2013-05-23 US claimed
EP-2535343-A2 Organoaminosilane precursors and methods for making and using same AIR PRODUCTS AND CHEMICALS, INC. (US) 2012-12-19 EP claimed
US-20260076110-A1 HYBRID ATOMIC LAYER DEPOSITION LAM RES CORP (US) 2026-03-12 US disclosed
US-20250372367-A1 DEPOSITION AND ETCH OF SILICON-CONTAINING LAYER LAM RES CORP (US) 2025-12-04 US disclosed
US-20250197996-A1 LOW-K DIELECTRIC PROTECTION DURING PLASMA DEPOSITION OF SILICON NITRIDE LAM RES CORP (US) 2025-06-19 US disclosed
US-20250188609-A1 SEAM-FREE AND CRACK-FREE DEPOSITION LAM RES CORP (US) 2025-06-12 US disclosed
US-20250166989-A1 THERMAL FILM DEPOSITION LAM RES CORP (US) 2025-05-22 US disclosed
CN-119604963-A Hybrid atomic layer deposition 朗姆研究公司 2025-03-11 CN disclosed
CN-119487614-A Deposition and etching of silicon-containing layers 朗姆研究公司 2025-02-18 CN disclosed
US-9005719-B2 Organoaminosilane precursors and methods for making and using same AIR PRODUCTS AND CHEMICALS, INC. (US) 2015-04-14 US disclosed
US-20140272194-A1 ORGANOAMINOSILANE PRECURSORS AND METHODS FOR MAKING AND USING SAME AIR PRODUCTS AND CHEMICALS, INC. (US) 2014-09-18 US disclosed
US-8771807-B2 Organoaminosilane precursors and methods for making and using same AIR PRODUCTS AND CHEMICALS, INC. (US) 2014-07-08 US disclosed
US-20130129940-A1 ORGANOAMINOSILANE PRECURSORS AND METHODS FOR MAKING AND USING SAME AIR PRODUCTS AND CHEMICALS, INC. (US) 2013-05-23 US disclosed
EP-2535343-A2 Organoaminosilane precursors and methods for making and using same AIR PRODUCTS AND CHEMICALS, INC. (US) 2012-12-19 EP disclosed
US-7439308-B2 Process for producing (meth)acrylic polymer terminated by crosslinkable silyl group KANEKA CORPORATION (JP) 2008-10-21 US disclosed
US-20050107547-A1 Process for producing (meth)acrylic polymer terminated by crosslinkable silyl group KANEKA CORPORATION (JP) 2005-05-19 US disclosed
EP-1498433-A1 PROCESS FOR PRODUCING (METH)ACRYLIC POLYMER TERMINATED BY CROSSLINKABLE SILYL GROUP KANEKA CORPORATION (JP) 2005-01-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130129940-A1 ORGANOAMINOSILANE PRECURSORS AND METHODS FOR MAKING AND USING SAME AOC1, FUCA1, CD99 CYP1A2 1107/4885TGM2 1293/4885ALDH1A1 1005/4885
US-20260076110-A1 HYBRID ATOMIC LAYER DEPOSITION NOS2, SFN, DSTYK CYP1A2 499/4885TGM2 3461/4885ALDH1A1 3404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.